582 related articles for article (PubMed ID: 15388486)
1. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.
Martin GR; Wallace LE; Hartmann B; Holst JJ; Demchyshyn L; Toney K; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G431-8. PubMed ID: 15388486
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
3. Systemic GLP-2 levels do not limit adaptation after distal intestinal resection.
Topstad D; Martin G; Sigalet D
J Pediatr Surg; 2001 May; 36(5):750-4. PubMed ID: 11329581
[TBL] [Abstract][Full Text] [Related]
4. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.
Taqi E; Wallace LE; de Heuvel E; Chelikani PK; Zheng H; Berthoud HR; Holst JJ; Sigalet DL
J Pediatr Surg; 2010 May; 45(5):987-95. PubMed ID: 20438940
[TBL] [Abstract][Full Text] [Related]
5. Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection.
Dahly EM; Gillingham MB; Guo Z; Murali SG; Nelson DW; Holst JJ; Ney DM
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G670-82. PubMed ID: 12505881
[TBL] [Abstract][Full Text] [Related]
6. Nutritional effects of the serial transverse enteroplasty procedure in experimental short bowel syndrome.
Kaji T; Tanaka H; Wallace LE; Kravarusic D; Holst J; Sigalet DL
J Pediatr Surg; 2009 Aug; 44(8):1552-9. PubMed ID: 19635304
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
[TBL] [Abstract][Full Text] [Related]
8. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
Otto Buczkowska E; Dworzecki T
Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
[TBL] [Abstract][Full Text] [Related]
9. GLP-2 levels in infants with intestinal dysfunction.
Sigalet DL; Martin G; Meddings J; Hartman B; Holst JJ
Pediatr Res; 2004 Sep; 56(3):371-6. PubMed ID: 15201402
[TBL] [Abstract][Full Text] [Related]
10. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
11. [Effects of glucagon-like peptide 2 on the adaptation of residual small bowel in a rat model of short bowel syndrome].
Wu GH; Chen J; Li H; Wu ZH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):441-4. PubMed ID: 17043970
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
[TBL] [Abstract][Full Text] [Related]
14. ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.
Bahrami J; Yusta B; Drucker DJ
Gastroenterology; 2010 Jun; 138(7):2447-56. PubMed ID: 20226187
[TBL] [Abstract][Full Text] [Related]
15. Differential Effects on Intestinal Adaptation Following Exogenous Glucagon-Like Peptide 2 Therapy With and Without Enteral Nutrition in Neonatal Short Bowel Syndrome [Formula: see text].
Lim DW; Diané A; Muto M; Vine DF; Nation PN; Wizzard PR; Sigalet DL; Bigam DL; Pencharz PB; Turner JM; Wales PW
JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):156-170. PubMed ID: 27660290
[TBL] [Abstract][Full Text] [Related]
16. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.
Kaji T; Tanaka H; Holst JJ; Redstone H; Wallace L; de Heuval E; Sigalet DL
Eur J Pharmacol; 2008 Oct; 596(1-3):138-45. PubMed ID: 18762180
[TBL] [Abstract][Full Text] [Related]
17. mRNA levels of dipeptidyl peptidase IV decrease during intestinal adaptation.
Dunphy JL; Justice FA; Taylor RG; Fuller PJ
J Surg Res; 1999 Nov; 87(1):130-3. PubMed ID: 10527714
[TBL] [Abstract][Full Text] [Related]
18. Treatment of suckling rats with GLP-2 plus dexamethasone increases the ileal uptake of fatty acids in later life.
Iordache C; Drozdowski L; Clandinin MT; Wild G; Todd Z; Thomson AB
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G54-9. PubMed ID: 15591587
[TBL] [Abstract][Full Text] [Related]
19. Bilirubin impairs intestinal regrowth following massive small bowel resection in a rat model.
Sukhotnik I; Shaoul R; Lieber M; Coran AG; Abassi Z; Shiloni E; Mogilner JG
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):16-22. PubMed ID: 19465868
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
